ALPHAGAN P OPHTHALMIC SOLUTION 0.15% W/V - HSA Drug Approval Details
Approvals/HSA/ALPHAGAN P OPHTHALMIC SOLUTION 0.15% W/V
Approved
THERAPEUTIC
ALPHAGAN P OPHTHALMIC SOLUTION 0.15% W/V
ALLERGAN SALES LLC (UNITED STATES)🇸🇬 Health Sciences Authority
Approval Date
Jun 26, 2003
Approval ID
e5b106fe7ceccadc
Company
ALLERGAN SALES LLC (UNITED STATES)
Type
Therapeutic
Approval Details
Approval Id
e5b106fe7ceccadc
Drug Name
ALPHAGAN P OPHTHALMIC SOLUTION 0.15% W/V
Product Name
ALPHAGAN P OPHTHALMIC SOLUTION 0.15% W/V
Approval Number
SIN12336P
Approval Date
2003-06-26
Registrant
ABBVIE PTE. LTD.
Licence Holder
ABBVIE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
SOLUTION
Dosage
<p><strong>DOSAGE AND ADMINISTRATION</strong><br>
The recommended dose is one drop of ALPHAGAN® P (brimonidine tartrate ophthalmic solution) 0.15% in the affected eye(s) three times daily, approximately 8 hours apart.<br>
If more than one topical ophthalmic drug is to be used, the different drugs should be instilled at least 5 minutes apart.</p>
Route Of Administration
OPHTHALMIC
Indication Info
<p><strong>INDICATIONS AND USAGE</strong><br>
ALPHAGAN® P is indicated for the lowering of intraocular pressure in patients with open-angle glaucoma or ocular hypertension.</p>
Contraindications
<p><strong>CONTRAINDICATIONS</strong><br>
ALPHAGAN® P is contraindicated in patients with hypersensitivity to brimonidine tartrate or any component of this medication. It is also contraindicated in patients receiving monoamine oxidase (MAO) inhibitor therapy and contraindicated in neonates and infants (children under the age of 2 years).</p>
